(Q38093728)

28 August 2017

title

Use of asenapine in clinical practice for the management of bipolar mania (English)

1 reference

28 August 2017

Ana M González-Pinto

3

0 references

author name string

Allan H Young

1

1 reference

28 August 2017

Alfredo Carlo Altamura

2

1 reference

28 August 2017

Bruno Millet

4

1 reference

28 August 2017

Klaus Wiedemann

5

1 reference

28 August 2017

language of work or name

English

0 references

publication date

27 March 2013

1 reference

Journal of Psychopharmacology

28 August 2017

published in

1 reference

28 August 2017

volume

27

1 reference

28 August 2017

issue

4 Suppl

1 reference

28 August 2017

page(s)

3-13

1 reference

Duration of untreated illness and suicide in bipolar disorder: a naturalistic study.

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1359786813482534

Historical perspectives and natural history of bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786813482534

Effect of asenapine on manic and depressive symptoms in bipolar I patients with mixed episodes: results from post hoc analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786813482534

Recovery and functional outcomes following olanzapine treatment for bipolar I mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786813482534

Prolactin, hyperprolactinaemia and antipsychotic treatment: a review and lessons for treatment of early psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786813482534

Mortality among first-admission patients with psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786813482534

A systematic review evaluating health-related quality of life, work impairment, and healthcare costs and utilization in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786813482534

Atypical antipsychotics in bipolar disorder: systematic review of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786813482534

A UK panel consensus on the initiation of aripiprazole for the treatment of bipolar mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786813482534

Antipsychotic drugs in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786813482534

Treatment of bipolar disorder: a systematic review of available data and clinical perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786813482534

Epidemiology, diagnosis and management of mixed mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786813482534

Poor long-term prognosis in mixed bipolar patients: 10-year outcomes in the Vitoria prospective naturalistic study in Spain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786813482534

Evidence-based guidelines for treating bipolar disorder: revised second edition--recommendations from the British Association for Psychopharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786813482534

Occupational disability in bipolar disorder: analysis of predictors of being on severe disablement benefit (PREBIS study data).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786813482534

The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786813482534

Poor adherence to treatment associated with a high recurrence in a bipolar disorder outpatient sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786813482534

The effect of antipsychotic medication on sexual function and serum prolactin levels in community-treated schizophrenic patients: results from the Schizophrenia Trial of Aripiprazole (STAR) study (NCT00237913).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786813482534

2-Year course of bipolar disorder type I patients in outpatient care: factors associated with remission and functional recovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786813482534

Adverse effects of prolactin in rodents and humans: breast and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786813482534

The long-term natural history of the weekly symptomatic status of bipolar I disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786813482534

Suicidal events and accidents in 216 first-episode bipolar I disorder patients: predictive factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786813482534

Costs of bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786813482534

Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786813482534

Treatment non-adherence in affective disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786813482534

Long-term treatment of bipolar disorder in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786813482534

A 3-week, randomized, placebo-controlled trial of asenapine in the treatment of acute mania in bipolar mania and mixed states

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786813482534

Asenapine versus olanzapine in acute mania: a double-blind extension study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786813482534

Asenapine in the treatment of acute mania in bipolar I disorder: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786813482534

Asenapine for long-term treatment of bipolar disorder: a double-blind 40-week extension study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786813482534

Prolactin awareness: an essential consideration for physical health in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786813482534

The metabolic effects of antipsychotic medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786813482534

Antipsychotic-induced hyperprolactinaemia, hypogonadism and osteoporosis in the treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786813482534

Randomised controlled trial of efficacy of teaching patients with bipolar disorder to identify early symptoms of relapse and obtain treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786813482534

Enhancement of treatment adherence among patients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786813482534

Functioning and disability in bipolar disorder: an extensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786813482534

Asenapine: a novel psychopharmacologic agent with a unique human receptor signature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786813482534

Atypical antipsychotics and pituitary tumors: a pharmacovigilance study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786813482534

Asenapine as adjunctive treatment for acute mania associated with bipolar disorder: results of a 12-week core study and 40-week extension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786813482534

Effects of asenapine on depressive symptoms in patients with bipolar I disorder experiencing acute manic or mixed episodes: a post hoc analysis of two 3-week clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786813482534

Baseline characteristics and outcomes in patients with first episode or multiple episodes of acute mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786813482534

The McLean-Harvard First-Episode Mania Study: Prediction of Recovery and First Recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786813482534

Weight gain in bipolar disorder: pharmacological treatment as a contributing factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786813482534

Bipolar mixed episodes and antidepressants: a cohort study of bipolar I disorder patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786813482534

Prevalence of mixed mania using 3 definitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786813482534

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786813482534

Sexual dysfunction in patients taking conventional antipsychotic medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786813482534

Dépistage et prise en charge du trouble bipolaire : Méthodologie

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786813482534

Dépistage et prise en charge du trouble bipolaire : Résultats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786813482534

21 January 2018

Identifiers

DOI

10.1177/1359786813482534

1 reference

28 August 2017

1 reference